Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Has anyone already taken a look at the 5 new test data files at
http://www.decisiondiagnostics.co/extra.html
Password is probably the same as the first five files.
I don't have the password so any comments are appreciated.
I bought more after reading the report at 15.5c. This report will be defended easily and gets thrown out when the FDA approval hits.
The SEC report arguments are laughable. All these statements are truthfully answered by Berman. What is their case again?
"In addition, as of
April 13, 2020, Berman, who alone drafted the press releases on behalf of DECN, stated or
suggested in interviews with staff that he:
• knew that the company had no COVID-19 test kits - They will make the kits once design is finalized through the development process
• had not seen any of DECN’s prototype COVID-19 test kits;Berman has not seen it personally but it does not say it does not exist.
• had no idea how many test kits DECN could produce;Berman has overstated the test kits production numbers.This is understood by all.This would depend on parts needed for the finalized design
• knew that the COVID-19 test kits would require component parts that were different from DECN’s current diabetes products, which the company did not yet have and would need before any sales could be made;This follows the dev process testing with gold/platinum parts.Putting a number here would be lying.
• was looking for sources that could provide the component parts but had no idea
how much the component parts would cost and the time it would take for the company to obtain the parts in the midst of the pandemic; and Why does SEC need this information.This is immaterial to the case
• knew that no COVID-19 test kits could be sold without FDA approval, which the
company did not have.True.Nothing to argue here
"sorry, i meant Antibody"
Nothing to be sorry about.Antigens are both foreign substances and also are produced in the body.
"I'd be surprised if it didn't catch the eye of the SEC given that they're already in the neighborhood."
SEC is not going to look at 450k of bad debt reported due to COVID. This is kinda getting ridiculous with the desperation... The SEC is not your daddy.
"I think if this were a movie I would buy a ticket"
The irony is you will probably need to use Genviro finger prick test to get in to watch this movie.
"Has DECN detected ANY SARS COV2 virions in any blood samples"
This might be news for you but give it a read.Now tell me again how the virus cannot be detected in the bloodstream.
https://www.cnn.com/2020/05/07/health/coronavirus-semen-china-health/index.html
"Just called TD Ameritrade"
I haven't called TD for years. There is no need to anymore. I guess you got in touch with their star rep called Johnny C cause he always gives the correct information.
"He stated it will be on the grey tomorrow, and confirmed they will not let you buy it, if on the grey.
TD Ameritrade is saying the same thing"
This is a LIE. I can trade Grey markets through TD. Buy orders go through fine.
Here are some common sense explanations about Universal Response,LLC.
-Universal Response is a two person company started out in Feb/March 2020. -They are brand new and it makes zero sense to have a physical location at this time when all businesses are shut down.
-They were hired to reach out to potential big buyers before the FDA approval
-They are wasting their time answering to DECN holder's questions about their legitimacy.They don't have to prove anything to you or any other DECN investor.
- The product will sell itself once it gets the FDA approval.Their job is easy and mostly starts at that time which is why Berman didn't invest on an expensive outfit.
Early Startups are small, run from the basement, cheap to engage but they work very hard to make a name out there. In this case they come with a good previous experience. Checks all my boxes.
"You're right LMAOOOO"
You finally got that one absolutely right. See you at 000s or whatever you decide the price should be.
SEC is not influenced by other organizations.They go after tickers by keyword in the current tulip mania and look at their trading patterns. In 2018 they did the same with tickers that used blockchain in their PRs. Now they are investigating and already suspended around 20 COVID tickers based on suspect PRs and trading patterns.They already have data on trading and they investigate the veracity of the PRs .They are not sending requests to other organizations like the WHO or the WHO Nots.
Also the WHO or CDC are never concerned about how any stock trades even if a ticker is "the panacea".
This is what SEC staff does at other times
https://www.cbsnews.com/news/sec-staffers-watched-porn-as-economy-crashed/
SEC is looking at the PRs and trading patterns.They called to verify the PRs and didn't get the answers they wanted cause the tests and approvals are not finalized yet.
They have no interest in the methodology behind the kits and they don't care if in the future the test passes the FDA process.
What stinks here is that people are gonna be stinking rich here when this is approved.
Are you talking about me? I have 200k shares.
CBS could care less about DECN's stock value or suspended status.
They should be verifying the product and its claims with the test results and the current FDA EUA status from multiple sources. Dr. Gomez and CBS have known about DECN's product for a while now (this confirms the earlier CBS report about California diabetes company ). There is no excuse for them to not spend the time to do their DD and verify the stunning claims that Berman is making.
These are already estimated to be the future issues:
production delays due to lack of workers ill due to COVID
shipping delays
lack of raw materials due to rare earth parts used in the device
Only 2 staff in korea both of whom smoke pot on job so nothing gets done.
and
the first devices absolutely cannot be produced before September 2020 because it was mentioned in a March PR.
"Berman says he was contacted by several large companies and FEMA to adapt it’s well-known diabetes testing technology into both a professional healthcare version and a home unit. Both are awaiting FDA approval."
This article also confirms that the second application is already submitted.We are in great shape.CBS will have done its DD before posting this already having known that DECN is under SEC suspension for alleged misleading claims.
Sit tight and hold on to your shares.
It's easy to get files that are not linked on their website if you go to
http://www.pharmatechsolutions.co/assets/
It must have been file they uploaded for future use and the miscreants just grabbed it for their personal gain.
"I see no mention of the word 'Perfected' hereabouts!? Do you?"
Nobody in this board questioned the use of "perfected" in the PR until the SEC raised it. Its a non issue and only a fool or ignorant would not be able to decode what it means in the context of usage.
From the Moderna PR
"The company also has the capability to manufacture the vaccine, but the deal with Lonza will increase its capacity by a factor of 10"
Have you personally verified their manufacturing facilities is able increase capacity by 10x? If not its not factual.
"to manufacture up to a billion doses per year "
They have to make exactly one billion otherwise its a fake PR. Upto means exactly one billion right just like upto 525 million means that. Is this factual or a forecast?
There is no reason to file the 550 petition as trading suspension will come off automatically in 10 days .The SEC will probably take a week to respond and there is almost no chance of suspension coming off within these 10 days.
Unlike NoBorders, Berman does not intend to invest valuable time in this nonsense when he has lot of kits and money to make. NoBorders' petition shows that their business will be decimated by the suspension. DECN not so much.
Grey market is fine as long as there's progress towards EUA approval.
I tried trading NoBorders on grey market yesterday with a small amount with TDA and there was no issue. Did not need to call in.
We have a major news event in the horizon and tons of people waiting to buy in.
The technology is "perfected" as in designed/redesigned to detect SARS-COV-2. The product was prototyped before the EUA application and now is in the advanced development stage before mass production.This is my understanding of the situation.
"Until a change is publicly disclosed, the projected SEPTEMBER 2020 availability is a FACT"
so this statement in the PR is fact and everything else about the tech and the very existence of the kit which was detailed in the same PR is fake.
September 2020 availability is fine as no sports arenas are gonna fully open before fall or end of year .Several other establishments opening later in the year would need lot more testing kits as well.
Yes Exactly.Unfortunately there will be people who will not do their homework and sell into this charade. With the number of suspensions going around experienced investors would not make a big deal of the DECN suspension. At other times the grey market would have been really bad but times are different now.I would rather be in a promising COVID ticker.
Agreed. DECNs reply to the suspension "Undaunted" compared to NB*R's "The damage to the reputation has virtually cut-off all access to the capital markets"
"The suspension order may cause NB*R to go out of business causing loss of jobs for employees" shows confidence.
There is no value in filing the 550 petition. Berman needs to deliver on the EUA approval and then apply for the second EUA application.
I'm sure we will hear more from Berman this week and next .
Berman should really explore the possibility of taking this thing private and sell the company once they get the EUA Approval.I know its gonna be pennies to the dollar of what they could have got but that time has passed IMO.
I am not sure what happens to shareholders at the grey markets if they take it private but sitting in the grey markets for months/years is not going to be good for any of us. What are your opinions on this?
Here it is
$DECN communication with the company still stands. PR coming Sunday night. This is a good sign. A fraudulent company would have cut off all communications. We still have hope. Facts about this suspension will be public Sunday night.
— Mo AK (@Black_Rose_MAK) April 24, 2020
Someone on twitter mentioned that they spoke with Berman and there is a PR coming out on Sunday night. It would be good if others call and confirm.
One thing I have learned is that it is risky to trade DECN. Let me explain.
Lots of people sold on Monday under 20c to buy back in at 15c on Tuesday but this went up the next few days upto to 49c. You will be able to sell at 40,50,60c but with the constant trading and with the stock moving higher you will end up either keeping your money out or hold fewer and fewer shares and wont make nearly as much as longs.Its nice to take profits and ride on so called "free shares" but buying on the way up will give you less shares to bank for the big run up.There will be a time when this will go up higher for days in a row without much dip and you will end missing the train because your target to buy back didn't hit.
The daily volume says a lot about the potential and with great PRs coming out this is geared to go into dollars.
At the end of the day if trading is your style then so be it but if you want to make some big money then hang tight for next 2-3 weeks.
Disclosure: I am sitting on around $31k of profit with DECN at EOD today $18k of which realized early this month but not selling since then.
So much for the miracle Abbott IDNow quick tests. Since each device takes 5 to 15 minutes to test and special solutions cannot be used to store the swabs for an extended period of time this has created a potential problem with re swabbing sick patients..uhh. There are hundreds of swabs waiting for testing without immediate access to a machine.
We need better testing. We need DECN.
https://www.cnn.com/2020/04/21/health/abbott-laboratories-coronavirus-rapid-test/index.html
Millions of masks and coronavirus test kits are sitting in warehouses and can't reach the US because of new Chinese policies
https://www.yahoo.com/news/millions-masks-coronavirus-test-kits-231230229.html
The vaccinations are not coming out to the general public till mid year at least and even then 100s of millions cannot be vaccinated within a few months .Drugs being available will cause little to no change in testing demand. There has been reports of relapse in COVID patient in South Korea so testing is vital there are no ifs about it.
https://en.yna.co.kr/view/AEN20200417006800320
Even when details of the patent and the specific methodology comes out it wont stop the same people questioning it to doubt its veracity.Then they would want to see it work in person. Even with FDA EUA there will be talk about shipping delays, manufacturing defects, inaccurate test and lazy factory workers that will contribute to the failure of this product.
As for a PnD stock especially if DECN is involved in such a scheme would they not release more fluff PRs to pump it. There has been dead silence since April 7th. Where is the pump? Who is pumping this stock? I don't see it.
They must have at the least be done with the 60 tests with favorable outcomes and submitted the final testing report to FDA to be able to post for filling up several employment positions to market Genviro. All IMO
Wow. This is a deal breaker for me.spelling error..Whhat?? Selling all shares now . Everyone do it!
Basically, it looks like the diabetes monitor is transferring blood sample images to the electron microscope, where the samples are then viewed by a technician to determine a tests outcome
Best joke I have heard in a month.
Please name the company that is doing this idiotic type of testing?
How does a diabetes monitor transfer these blood sample images to the electron microscope? Name the methodology.
DECN's finger prick tests can tap several rich communties like the one mentioned in this article. They will need daily testing for their staff.
https://www.yahoo.com/news/everyone-wants-antibody-test-everyone-121422536.html
Assuming that Dr. Max Gomez (CBS) on that news piece knows about all the technologies behind the current EUA pipeline devices is preposterous. He said the following
" a California company uses an existing diabetes monitor that actually identifies the virus based on a digitized electron microscope picture."
Digitized electron microscope picture is a close enough description of Genviro's spectroscopy methodology and unless someone can name another company with existing diabetes monitor doing this it can be safely assumed that this is DECN.
The fact that he mentioned this device in such detail means someone likely from the FDA gave him information on these new and innovative tests and they have eyes on this one.
DECN was in the business of making diabetes strips (still is in part). Even though the market is 10 Billion it is highly saturated market with big piece of the pies taken by large cap companies years ago .None of the new tech is able to get a fair market share in the diabetes market.
If you were invested in a diabetes strip manufacturing company then you deserve to lose money in the last 4 years. I was in another ticker(DRIO) and they bled every year and still continue to bleed.
If you bought into this company thinking they would win a lawsuit against JNJ then you deserve to lose your money.
Now their main focus is COVID test strips and comparing them with previous performance as a diabetes strip company is nonsense at the least. They were using impedance tech for the diabetes strips so they already had one part of the puzzle figured. They could leverage their knowledge in this field to come up with this product. Kudos to the DECN team
As an end note I believe since the CEO and the rest of the board is pretty old he might be inclined to sell the company and cash out.
Some excerpts from the financial report
"The company’s
GenUltimate TBG product makes use of impedance technology to measure the number of red blood cells in a patient blood sample,
information relevant to a glucose measurement in that same patient. Mr. Berman, the company’s CEO, became convinced that a similarly
configured device could be built for the determination of Covid-19"
"The specifications guidelines set down by Mr. Berman, for creating this Covid-19 testing device and its important chemistry,
were that the test must be measured on the company’s existing Precise or Avantage glucometers, because they were completed products,
having been tested to great length, and now to be adapted for detection of Covid-19 instead of whole blood glucose. In addition, the
resulting chemistry would necessarily run using a patients (small sample of) whole blood taken from a finger prick, and later defined as
1-2 microliters (a small drop on a finger tip), and perform the test and provide a result in one minute or less (later redefined as 15 seconds
or less), with at least a 95% accuracy. Mr. Berman believed this device was capable of 97-98% accuracy. "
--Know what you own or eat Ra(w)men.
No major sporting event till thanksgiving in Santa Clara - home of 49ers
Covid Cases in Bay area are increasing the past few days despite shelter in place for 5 weeks now.
Even if the test kits are available in September these kits will be in high demand.
https://www.mercurynews.com/2020/04/08/coronavirus-top-official-says-sports-unlikely-before-thanksgiving-in-santa-clara-county/